Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free CRDL Stock Alerts

Cardiol Therapeutics (CRDL) Competitors

Cardiol Therapeutics logo
C$1.67 -0.07 (-4.02%)
As of 07/24/2026 04:24 PM Eastern
Compare

CRDL vs. TLRY, ITH, TEV, NOT, and PYR

Should you buy Cardiol Therapeutics stock or one of its competitors? MarketBeat compares Cardiol Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardiol Therapeutics include Tilray Brands (TLRY), International Tower Hill Mines (ITH), Tervita (TEV), Noront Resources (NOT), and PyroGenesis Canada Inc. (PYR.V) (PYR). These companies are all part of the "pharmaceutical products" industry.

How does Cardiol Therapeutics compare to Tilray Brands?

Cardiol Therapeutics (TSE:CRDL) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

0.1% of Cardiol Therapeutics shares are held by institutional investors. Comparatively, 4.2% of Tilray Brands shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cardiol Therapeutics has higher earnings, but lower revenue than Tilray Brands. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A
Tilray BrandsC$858.28M0.79-C$183.24M-C$14.63N/A

Cardiol Therapeutics has a beta of 0.300183, indicating that its share price is 70% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.0845, indicating that its share price is 208% more volatile than the broader market.

Cardiol Therapeutics has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Tilray Brands' return on equity of -88.06% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardiol TherapeuticsN/A -229.16% -54.15%
Tilray Brands -158.75%-88.06%-1.41%

Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 142.26%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cardiol Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardiol Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Tilray Brands had 2 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Cardiol Therapeutics. Cardiol Therapeutics' average media sentiment score of 0.00 beat Tilray Brands' score of -0.02 indicating that Cardiol Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Cardiol Therapeutics Neutral
Tilray Brands Neutral

Summary

Tilray Brands beats Cardiol Therapeutics on 9 of the 14 factors compared between the two stocks.

How does Cardiol Therapeutics compare to International Tower Hill Mines?

Cardiol Therapeutics (TSE:CRDL) and International Tower Hill Mines (TSE:ITH) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Cardiol Therapeutics has a beta of 0.300183, meaning that its share price is 70% less volatile than the broader market. Comparatively, International Tower Hill Mines has a beta of 2.361834, meaning that its share price is 136% more volatile than the broader market.

International Tower Hill Mines is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A
International Tower Hill MinesN/AN/A-C$2.36M-C$0.01N/A

International Tower Hill Mines' return on equity of -1.99% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardiol TherapeuticsN/A -229.16% -54.15%
International Tower Hill Mines N/A -1.99%-3.65%

In the previous week, Cardiol Therapeutics' average media sentiment score of 0.00 equaled International Tower Hill Mines'average media sentiment score.

Company Overall Sentiment
Cardiol Therapeutics Neutral
International Tower Hill Mines Neutral

0.1% of Cardiol Therapeutics shares are held by institutional investors. Comparatively, 9.2% of International Tower Hill Mines shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Comparatively, 0.5% of International Tower Hill Mines shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

International Tower Hill Mines beats Cardiol Therapeutics on 6 of the 8 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Tervita?

Tervita (TSE:TEV) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

Tervita's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
TervitaN/A N/A N/A
Cardiol Therapeutics N/A -229.16%-54.15%

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Tervita's average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Tervita Neutral
Cardiol Therapeutics Neutral

Tervita has higher revenue and earnings than Cardiol Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Tervita, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TervitaC$1.36B0.00-C$1.04M-C$0.01N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

Summary

Tervita beats Cardiol Therapeutics on 5 of the 8 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Noront Resources?

Noront Resources (CVE:NOT) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

0.1% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Noront Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Noront ResourcesN/A N/A N/A
Cardiol Therapeutics N/A -229.16%-54.15%

In the previous week, Noront Resources' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Noront Resources Neutral
Cardiol Therapeutics Neutral

Noront Resources is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noront ResourcesN/AN/AN/A-C$0.15N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

Summary

Noront Resources and Cardiol Therapeutics tied by winning 3 of the 6 factors compared between the two stocks.

How does Cardiol Therapeutics compare to PyroGenesis Canada Inc. (PYR.V)?

PyroGenesis Canada Inc. (PYR.V) (CVE:PYR) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

In the previous week, PyroGenesis Canada Inc. (PYR.V)'s average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
PyroGenesis Canada Inc. (PYR.V) Neutral
Cardiol Therapeutics Neutral

PyroGenesis Canada Inc. (PYR.V) has higher revenue and earnings than Cardiol Therapeutics. PyroGenesis Canada Inc. (PYR.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PyroGenesis Canada Inc. (PYR.V)C$6.01M100.97-C$3.94M-C$0.03N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

PyroGenesis Canada Inc. (PYR.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
PyroGenesis Canada Inc. (PYR.V)N/A N/A N/A
Cardiol Therapeutics N/A -229.16%-54.15%

0.1% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

PyroGenesis Canada Inc. (PYR.V) beats Cardiol Therapeutics on 5 of the 8 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRDL vs. The Competition

Export
MetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$200.57MC$2.25BC$6.88BC$12.48B
Dividend YieldN/A2.81%2.67%6.19%
P/E Ratio-4.285.0027.0036.95
Price / SalesN/A1,642.24492.669.44
Price / Cash0.9810.1850.5482.29
Price / Book7.529.9110.284.39
Net Income-C$42.93MC$20.27BC$3.60BC$299.09M
7 Day Performance-1.18%-0.87%-1.25%0.61%
1 Month Performance10.60%0.08%-0.35%1.06%
1 Year Performance-14.80%7.16%18.41%30.89%

Cardiol Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
N/AC$1.67
-4.0%		N/A-13.0%C$200.57MN/AN/A20
TLRY
Tilray Brands
1.3165 of 5 stars		C$6.06
-0.8%		C$13.30
+119.5%		-43.4%C$748.15MC$858.28MN/A2,650
ITH
International Tower Hill Mines
N/AC$2.81
+0.4%		N/A+93.3%C$735.20MN/AN/A220
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36BN/A36,800
NOT
Noront Resources
N/AC$1.10
-0.5%		N/A+0.0%C$612.18MN/AN/A101,700

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:CRDL) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel